# Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease

> **NCT01136564** · PHASE2 · COMPLETED · sponsor: **Erling Bjerregaard Pedersen** · enrollment: 30 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Zemplar
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01136564
- **Lead sponsor:** Erling Bjerregaard Pedersen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136564, "Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01136564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*